Teruhiko Terasawa

Summary

Affiliation: Tufts Medical Center
Country: USA

Publications

  1. doi request reprint Current clinical evidence on interim fluorine-18 fluorodeoxy glucose positron emission tomography for advanced-stage Hodgkin lymphoma and diffuse large B-cell lymphoma to predict treatment outcomes
    Teruhiko Terasawa
    Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA 02111, USA
    Leuk Lymphoma 50:1750-2. 2009
  2. doi request reprint Comparative efficacy of first-line therapies for advanced-stage chronic lymphocytic leukemia: a multiple-treatment meta-analysis
    Teruhiko Terasawa
    Department of Internal Medicine, Nanakuri Sanatorium, Fujita Health University School of Medicine, Tsu, Japan
    Cancer Treat Rev 39:340-9. 2013
  3. doi request reprint Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review
    Teruhiko Terasawa
    Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA 02111, USA
    J Clin Oncol 27:1906-14. 2009
  4. ncbi request reprint Systematic review: charged-particle radiation therapy for cancer
    Teruhiko Terasawa
    Tufts Medical Center Evidence based Practice Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA
    Ann Intern Med 151:556-65. 2009
  5. pmc Fluorine-18-fluorodeoxyglucose positron emission tomography in response assessment before high-dose chemotherapy for lymphoma: a systematic review and meta-analysis
    Teruhiko Terasawa
    Fujita Health University Nanakuri Sanatorium, 424 1 Odoricho, Tsu, Mie, 514 1295, Japan
    Oncologist 15:750-9. 2010
  6. doi request reprint Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force
    Mei Chung
    Tufts Evidence based Practice Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts 02111, USA
    Ann Intern Med 155:827-38. 2011
  7. doi request reprint Predictors of atrial fibrillation recurrence after radiofrequency catheter ablation: a systematic review
    Ethan M Balk
    Tufts Evidence based Practice Center, TuftsMedical Center, Boston, Massachusetts, USA
    J Cardiovasc Electrophysiol 21:1208-16. 2010
  8. ncbi request reprint 18F-FDG PET for posttherapy assessment of Hodgkin's disease and aggressive Non-Hodgkin's lymphoma: a systematic review
    Teruhiko Terasawa
    Clinical Research Center for Blood Diseases, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
    J Nucl Med 49:13-21. 2008
  9. pmc Systematic review to support the development of nutrient reference intake values: challenges and solutions
    Mei Chung
    Tufts Evidence based Practice Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA02111, USA
    Am J Clin Nutr 92:273-6. 2010
  10. doi request reprint Systematic review: Anti-epidermal growth factor receptor treatment effect modification by KRAS mutations in advanced colorectal cancer
    Issa J Dahabreh
    Center for Clinical Evidence Synthesis, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts 02111, USA
    Ann Intern Med 154:37-49. 2011

Detail Information

Publications13

  1. doi request reprint Current clinical evidence on interim fluorine-18 fluorodeoxy glucose positron emission tomography for advanced-stage Hodgkin lymphoma and diffuse large B-cell lymphoma to predict treatment outcomes
    Teruhiko Terasawa
    Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA 02111, USA
    Leuk Lymphoma 50:1750-2. 2009
    ..Its use should currently be reserved for research studies where treatment strategies and imaging protocols are standardized...
  2. doi request reprint Comparative efficacy of first-line therapies for advanced-stage chronic lymphocytic leukemia: a multiple-treatment meta-analysis
    Teruhiko Terasawa
    Department of Internal Medicine, Nanakuri Sanatorium, Fujita Health University School of Medicine, Tsu, Japan
    Cancer Treat Rev 39:340-9. 2013
    ..In conclusion, published randomized evidence on overall survival is insufficient to recommend any particular first-line treatments. Any progression-free survival differences may be applicable to relatively young uncomplicated patients...
  3. doi request reprint Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review
    Teruhiko Terasawa
    Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA 02111, USA
    J Clin Oncol 27:1906-14. 2009
    ....
  4. ncbi request reprint Systematic review: charged-particle radiation therapy for cancer
    Teruhiko Terasawa
    Tufts Medical Center Evidence based Practice Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA
    Ann Intern Med 151:556-65. 2009
    ..Radiation therapy with charged particles can potentially deliver maximum doses while minimizing irradiation of surrounding tissues, and it may be more effective or less harmful than other forms of radiation therapy...
  5. pmc Fluorine-18-fluorodeoxyglucose positron emission tomography in response assessment before high-dose chemotherapy for lymphoma: a systematic review and meta-analysis
    Teruhiko Terasawa
    Fujita Health University Nanakuri Sanatorium, 424 1 Odoricho, Tsu, Mie, 514 1295, Japan
    Oncologist 15:750-9. 2010
    ....
  6. doi request reprint Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force
    Mei Chung
    Tufts Evidence based Practice Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts 02111, USA
    Ann Intern Med 155:827-38. 2011
    ..Studies suggest that vitamin D supplementation may reduce cancer and fracture risks...
  7. doi request reprint Predictors of atrial fibrillation recurrence after radiofrequency catheter ablation: a systematic review
    Ethan M Balk
    Tufts Evidence based Practice Center, TuftsMedical Center, Boston, Massachusetts, USA
    J Cardiovasc Electrophysiol 21:1208-16. 2010
    ..AF Recurrence After RFA: Systematic Review...
  8. ncbi request reprint 18F-FDG PET for posttherapy assessment of Hodgkin's disease and aggressive Non-Hodgkin's lymphoma: a systematic review
    Teruhiko Terasawa
    Clinical Research Center for Blood Diseases, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
    J Nucl Med 49:13-21. 2008
    ..The aim of this study was to systematically review the diagnostic accuracy of (18)F-FDG PET in detecting residual disease at the completion of first-line therapy of Hodgkin's disease (HD) and aggressive non-Hodgkin's lymphoma (NHL)...
  9. pmc Systematic review to support the development of nutrient reference intake values: challenges and solutions
    Mei Chung
    Tufts Evidence based Practice Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA02111, USA
    Am J Clin Nutr 92:273-6. 2010
    ..The experiences described in this article can serve as a basis for future improvements in systematic reviews of nutrients and to better integrate systematic review into development of future nutrient reference values...
  10. doi request reprint Systematic review: Anti-epidermal growth factor receptor treatment effect modification by KRAS mutations in advanced colorectal cancer
    Issa J Dahabreh
    Center for Clinical Evidence Synthesis, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts 02111, USA
    Ann Intern Med 154:37-49. 2011
    ..KRAS mutations have been extensively investigated as predictive biomarkers for treatment of advanced colorectal cancer with the anti-epidermal growth factor receptor (EGFR) antibodies cetuximab and panitumumab...
  11. pmc CYP2D6 testing to predict response to tamoxifen in women with breast cancer: Pharmacogenomic
    Issa Dahabreh
    ICRHPS, Tufts Medical Center Department of Internal Medicine, Fujita Health University School of Medicine Tufts Medical Center and Tufts Evidence based Practice Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center
    PLoS Curr 2:RRN1176. 2010
    ..A test predicting lack of response to tamoxifen could supplement information used by clinicians and patients in treatment decision-making. For example, physicians and patients may opt to switch to an alternative therapy upfront...
  12. ncbi request reprint Systematic review: comparative effectiveness of radiofrequency catheter ablation for atrial fibrillation
    Teruhiko Terasawa
    Tufts Medical Center, Boston, Massachusetts 02111, USA
    Ann Intern Med 151:191-202. 2009
    ..Atrial fibrillation is the most common sustained arrhythmia. Medical treatment often fails to control symptoms...
  13. pmc BCR-ABL mutation testing to predict response to tyrosine kinase inhibitors in patients with chronic myeloid leukemia
    Teruhiko Terasawa
    Department of Internal Medicine, Fujita Health University School of Medicine ICRHPS, Tufts Medical Center and Tufts Evidence based Practice Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center
    PLoS Curr 2:RRN1204. 2010
    ..Testing for mutations in BCR-ABL1 may predict lack of response to imatinib or may inform the choice between alternative TKIs...